Abiopharma

News list

📋 SAGAN PAUL (Ex-Director) plans to sell 37K shares of Moderna, Inc. (at $54.48 each, total $2.0M) Filed: May 08, 2026 | ID: 003415

Full text

News bot May 8, 2026, 3:24 p.m.
📋 Form 144 Filing: SAGAN PAUL

Company: Moderna, Inc.

Filing Date: 2026-05-08

Relationship: Former Director
Planned Sale Details:
- Security: Common
- Shares to be Sold: 36,759
- Price per Share: $54.48
- Total Value: $2,002,786.85
- Planned Sale Date: 2026-05-08
- Broker: Fidelity Brokerage Services LLC
- Exchange: NASDAQ
Additional Information:
- SEC File Number: 001-38753
- Issuer Contact Phone: 6177146500
- Issuer Address: 325 BINNEY STREET, CAMBRIDGE, MA, 02142
- Broker Address: 900 Salem Street, Smithfield, RI, 02917
- Shares Outstanding: 396786259.0
- Number of Securities to be Sold: 1
- Signature: /s/ Gary Redman, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Paul Sagan